High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries.
暂无分享,去创建一个
Roberto G Lucchini | Laura Benedetti | Lorenzo Alessio | G. Parrinello | L. Alessio | Giovanni Parrinello | Elisa Albini | R. Lucchini | Sergio Resola | Stefano Borghesi | Romana Coccaglio | Eros C Malara | Siria Garattini | E. Albini | S. Resola | R. Coccaglio | L. Benedetti | S. Borghesi | E. Malara | S. Garattini
[1] Michael Jerrett,et al. A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. , 2007, Environmental research.
[2] K. Leenders,et al. Hydrocarbon exposure and Parkinson’s disease , 2000, Neurology.
[3] K. Teschke,et al. The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology. , 2003, Parkinsonism & related disorders.
[4] F. Larribe,et al. Bioindicator and exposure data for a population based study of manganese. , 1999, Neurotoxicology.
[5] M. Egyed,et al. Risk assessment for combustion products of the gasoline additive MMT in Canada , 1996 .
[6] J. Texcalac-Sangrador,et al. Exposure to manganese: health effects on the general population, a pilot study in central Mexico. , 2001, Environmental research.
[7] B. Sonawane,et al. Neurodegenerative Diseases: An Overview of Environmental Risk Factors , 2005, Environmental health perspectives.
[8] P. Landrigan,et al. The Declaration of Brescia on prevention of the neurotoxicity of metals June 18, 2006. , 2006, American journal of industrial medicine.
[9] Freya Kamel,et al. Association of Pesticide Exposure with Neurologic Dysfunction and Disease , 2004, Environmental health perspectives.
[10] K. Bötzel,et al. Prevalence and incidence of Parkinson's disease in Europe , 2005, European Neuropsychopharmacology.
[11] D. Jennings,et al. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders , 2005, Neurology.
[12] G. Román,et al. Worldwide occurrence of Parkinson's disease: an updated review. , 1993, Neuroepidemiology.
[13] A. Vyskočil,et al. Environmental contamination and human exposure to manganese – contribution of methylcyclopentadienyl manganese tricarbonyl in unleaded gasoline , 1999, International archives of occupational and environmental health.
[14] W. Koller,et al. The diagnosis of manganese-induced parkinsonism. , 2006, Neurotoxicology.
[15] G. Meco,et al. Estimate of parkinsonism prevalence through drug prescription histories in the Province of Rome, Italy , 1995, Acta neurologica Scandinavica.
[16] Daniel J Schaid,et al. Risk tables for parkinsonism and Parkinson's disease. , 2002, Journal of clinical epidemiology.
[17] Bernard Weiss,et al. Economic implications of manganese neurotoxicity. , 2006, Neurotoxicology.
[18] Zhenxin Zhang,et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai , 2005, The Lancet.
[19] P. Apostoli,et al. Are current biomarkers suitable for the assessment of manganese exposure in individual workers? , 2000, American journal of industrial medicine.
[20] P Apostoli,et al. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. , 1995, Scandinavian journal of work, environment & health.
[21] H. Kay. Environmental Health Criteria , 1980 .
[22] T. Videen,et al. [18F]FDOPA PET and clinical features in parkinsonism due to manganism , 2005, Movement disorders : official journal of the Movement Disorder Society.
[23] M. Allam,et al. Parkinson's disease risk factors: genetic, environmental, or both? , 2005, Neurological research.
[24] P Apostoli,et al. Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. , 1999, Neurotoxicology.
[25] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[26] U. Siebert,et al. Cost of Parkinson's disease in Europe , 2005, European journal of neurology.
[27] A. Chiò,et al. Prevalence of Parkinson's disease in northwestern italy: Comparison of tracer methodology and clinical ascertainment of cases , 1998, Movement disorders : official journal of the Movement Disorder Society.
[28] Samuel M. Goldman,et al. EPIDEMIOLOGY OF PARKINSON'S DISEASE , 1996, Neurologic Clinics.
[29] S. Sacco,et al. Prevalence of Parkinson's disease in the L'Aquila district, central Italy , 2005, Acta neurologica Scandinavica.
[30] J. Mink,et al. Welding-related parkinsonism , 2001, Neurology.
[31] Joshua M. Pearce,et al. Neurodegeneration with Brain Iron Accumulation: A Cautionary Tale , 2006, European Neurology.
[32] Christopher J. Martin. Manganese neurotoxicity: connecting the dots along the continuum of dysfunction. , 2006, Neurotoxicology.
[33] M. Farrer. Genetics of Parkinson disease: paradigm shifts and future prospects , 2006, Nature Reviews Genetics.
[34] J. Roth,et al. Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. , 2003, Biochemical pharmacology.
[35] Carlos Santos-Burgoa,et al. Motor alterations associated with exposure to manganese in the environment in Mexico. , 2006, The Science of the total environment.
[36] E. Love,et al. Parkinson's disease and exposure to agricultural work and pesticide chemicals , 1992, Neurology.
[37] O. Axelson,et al. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. , 1996, Journal of clinical epidemiology.